Evaluation of housekeeping genes in placental comparative expression studies

被引:180
作者
Meller, M [1 ]
Vadachkoria, S
Luthy, DA
Williams, MA
机构
[1] Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA 98122 USA
[2] Obstetrix Med Grp, Seattle, WA USA
[3] Univ Washington, Dept Epidemiol, Sch Publ Hlth & Community Med, Seattle, WA 98195 USA
关键词
real time PCR; mRNA expression; endogenous housekeeping genes; internal standards; placenta;
D O I
10.1016/j.placenta.2004.09.009
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Preeclampsia and diabetes are complications of pregnancy that contribute to maternal and perinatal mortality worldwide. Results emerging from molecular studies of placentae may elucidate etiologically important genomic alterations. Appropriate application of real time reverse transcription (RT) PCR in comparative gene expression studies requires endogenous housekeeping genes to normalize between sample variations. Ideal housekeeping genes must have stable tissue expression, but few have been specifically studied in the placenta. We sought to identify candidate control genes by analyzing seven functionally distinct housekeeping genes (B2M, GAPDH, HMBS, HPRT, SDHA, TBP, YWHAZ) for their expression stability and level in the placenta. mRNA isolated from 20 placentae was analyzed for gene expression using RT-PCR. Expression stability (M) was assessed using normalization strategies previously used for other tissues. TBP and SDHA were the most stable, with an average expression stability of M = 0.43, followed by YWHAZ (M = 0.44) > HPRT (M = 0.53) > HMBS (M = 0.57) > GAPDH (M = 0.61) > B2M (M = 0.69). The genes tested ranged in abundance, with an approximately 300-fold increase from the lowest (HMBS) to the highest (B2M). By using TBP, SDHA and YWHAZ, with greater expression stability than those housekeeping genes commonly used in placenta studies, gene expression profile comparisons will have more sensitivity and specificity.
引用
收藏
页码:601 / 607
页数:7
相关论文
共 20 条
[1]  
ALEXANDERBRIDGES M, 1992, MOL CELL BIOCHEM, V109, P99
[2]   Prospective function of placental leptin at maternal-fetal interface [J].
Bajoria, R ;
Sooranna, SR ;
Ward, BS ;
Chatterjee, R .
PLACENTA, 2002, 23 (2-3) :103-115
[3]  
Bloomgarden Z T, 2000, Diabetes Care, V23, P1699, DOI 10.2337/diacare.23.11.1699
[4]   Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems [J].
Bustin, SA .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2002, 29 (01) :23-39
[5]  
Gant NF, 1996, INT J GYNECOL OBSTET, V53, P175
[6]  
Ishitani R, 1996, J PHARMACOL EXP THER, V278, P447
[7]   Overexpression of placental leptin in diabetic pregnancy - A critical role for insulin [J].
Lepercq, J ;
Cauzac, M ;
Lahlou, N ;
Timsit, J ;
Girard, J ;
Auwerx, J ;
Hauguel-de Mouzon, S .
DIABETES, 1998, 47 (05) :847-850
[8]   Placental peptides as markers of gestational disease [J].
Page, NM ;
Kemp, CF ;
Butlin, DJ ;
Lowry, PJ .
REPRODUCTION, 2002, 123 (04) :487-495
[9]   Analysis of GAPDH as a standard for gene expression quantification in human placenta [J].
Patel, P ;
Boyd, CAR ;
Johnston, DG ;
Williamson, C .
PLACENTA, 2002, 23 (8-9) :697-698
[10]   Leptin and Preeclampsia [J].
Poston, L .
SEMINARS IN REPRODUCTIVE MEDICINE, 2002, 20 (02) :131-138